diffuse large b cell lymphoma cell line oci ly18 (DSMZ)
DSMZ is a verified supplier 
94
Structured Review
DSMZ
diffuse large b cell lymphoma cell line oci ly18
Diffuse Large B Cell Lymphoma Cell Line Oci Ly18, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 37 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diffuse+large+b+cell+lymphoma+cell+line+oci+ly18/OCI-LY18/us12441812-1851-107-115
Average 94 stars, based on 37 article reviews
Diffuse Large B Cell Lymphoma Cell Line Oci Ly18, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 37 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diffuse+large+b+cell+lymphoma+cell+line+oci+ly18/OCI-LY18/us12441812-1851-107-115
Average 94 stars, based on 37 article reviews
diffuse large b cell lymphoma cell line oci ly18 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Binding Assay:Article Title: Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules Article Snippet: .. TABLE 78 Binding on activated 4-1BB-expressing CD4+ T cells and CD8+ T cells EC50 [nM] EC50 [nM] Construct 4-1BB+CD8+ 4-1BB+CD4+ Control B 0.05 0.26 Control C 0.02 0.30 Control D 0.04 0.28 Control E 0.13 1.22 3.1 0.03 0.28 3.3 0.01 0.29 3.4 0.15 2.04 3.5 0.04 1.03 3.6 0.05 0.21 9.2 Binding to CD19-Expressing Tumor Cells For binding assays on CD19-expressing tumor cells, the following human CD19-expressing lymphoma cell lines were used: diffuse large non-Hodgkin B cell lymphoma (B-NHL) cell line SU-DHL-8 (DSMZ ACC573), acute B cell precursor lymphoid leukemia cell line Nalm6 (DSMZ ACC-128), diffuse large cell lymphoblast lymphoma cell line Toledo (ATCC CRL-2631) and Article Title: Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer Article Snippet: .. For binding assays on CD19-expressing tumor cells, the following human CD19-expressing lymphoma cell lines were used: diffuse large non-Hodgkin B cell lymphoma (B-NHL) cell line SU-DHL-8 (DSMZ ACC573), acute B cell precursor lymphoid leukemia cell line Nalm6 (DSMZ ACC-128), diffuse large cell lymphoblast lymphoma cell line Toledo (ATCC CRL-2631) and Article Title: Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer Article Snippet: .. TABLE 78 Binding on activated 4-1BB-expressing CD4+ T cells and CD8 + T cells EC50 [nM] EC50 [nM] Construct 4-1BB+CD8+ 4-1BB+CD4+ Control B 0.05 0.26 Control C 0.02 0.30 Control D 0.04 0.28 Control E 0.13 1.22 3.1 0.03 0.28 3.3 0.01 0.29 3.4 0.15 2.04 3.5 0.04 1.03 3.6 0.05 0.21 9.2 Binding to CD19-Expressing Tumor Cells For binding assays on CD19-expressing tumor cells, the following human CD19-expressing lymphoma cell lines were used: diffuse large non-Hodgkin B cell lymphoma (B-NHL) cell line SU-DHL-8 (DSMZ ACC573), acute B cell precursor lymphoid leukemia cell line Nalm6 (DSMZ ACC-128), diffuse large cell lymphoblast lymphoma cell line Toledo (ATCC CRL-2631) and Article Title: Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules Article Snippet: .. TABLE 78 Binding on activated 4-1BB-expressing CD4+ T cells and CD8+ T cells EC50 [nM] EC50 [nM] Construct 4-1BB+CD8+ 4-1BB+CD4+ Control B 0.05 0.26 Control C 0.02 0.30 Control D 0.04 0.28 Control E 0.13 1.22 3.1 0.03 0.28 3.3 0.01 0.29 3.4 0.15 2.04 3.5 0.04 1.03 3.6 0.05 0.21 9.2 Binding to CD19-Expressing Tumor Cells For binding assays on CD19-expressing tumor cells, the following human CD19-expressing lymphoma cell lines were used: diffuse large non-Hodgkin B cell lymphoma (B-NHL) cell line SU-DHL-8 (DSMZ ACC573), acute B cell precursor lymphoid leukemia cell line Nalm6 (DSMZ ACC-128), diffuse large cell lymphoblast lymphoma cell line Toledo (ATCC CRL-2631) and Construct:Article Title: Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules Article Snippet: .. TABLE 78 Binding on activated 4-1BB-expressing CD4+ T cells and CD8+ T cells EC50 [nM] EC50 [nM] Construct 4-1BB+CD8+ 4-1BB+CD4+ Control B 0.05 0.26 Control C 0.02 0.30 Control D 0.04 0.28 Control E 0.13 1.22 3.1 0.03 0.28 3.3 0.01 0.29 3.4 0.15 2.04 3.5 0.04 1.03 3.6 0.05 0.21 9.2 Binding to CD19-Expressing Tumor Cells For binding assays on CD19-expressing tumor cells, the following human CD19-expressing lymphoma cell lines were used: diffuse large non-Hodgkin B cell lymphoma (B-NHL) cell line SU-DHL-8 (DSMZ ACC573), acute B cell precursor lymphoid leukemia cell line Nalm6 (DSMZ ACC-128), diffuse large cell lymphoblast lymphoma cell line Toledo (ATCC CRL-2631) and Article Title: Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer Article Snippet: .. TABLE 78 Binding on activated 4-1BB-expressing CD4+ T cells and CD8 + T cells EC50 [nM] EC50 [nM] Construct 4-1BB+CD8+ 4-1BB+CD4+ Control B 0.05 0.26 Control C 0.02 0.30 Control D 0.04 0.28 Control E 0.13 1.22 3.1 0.03 0.28 3.3 0.01 0.29 3.4 0.15 2.04 3.5 0.04 1.03 3.6 0.05 0.21 9.2 Binding to CD19-Expressing Tumor Cells For binding assays on CD19-expressing tumor cells, the following human CD19-expressing lymphoma cell lines were used: diffuse large non-Hodgkin B cell lymphoma (B-NHL) cell line SU-DHL-8 (DSMZ ACC573), acute B cell precursor lymphoid leukemia cell line Nalm6 (DSMZ ACC-128), diffuse large cell lymphoblast lymphoma cell line Toledo (ATCC CRL-2631) and Article Title: Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules Article Snippet: .. TABLE 78 Binding on activated 4-1BB-expressing CD4+ T cells and CD8+ T cells EC50 [nM] EC50 [nM] Construct 4-1BB+CD8+ 4-1BB+CD4+ Control B 0.05 0.26 Control C 0.02 0.30 Control D 0.04 0.28 Control E 0.13 1.22 3.1 0.03 0.28 3.3 0.01 0.29 3.4 0.15 2.04 3.5 0.04 1.03 3.6 0.05 0.21 9.2 Binding to CD19-Expressing Tumor Cells For binding assays on CD19-expressing tumor cells, the following human CD19-expressing lymphoma cell lines were used: diffuse large non-Hodgkin B cell lymphoma (B-NHL) cell line SU-DHL-8 (DSMZ ACC573), acute B cell precursor lymphoid leukemia cell line Nalm6 (DSMZ ACC-128), diffuse large cell lymphoblast lymphoma cell line Toledo (ATCC CRL-2631) and Control:Article Title: Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules Article Snippet: .. TABLE 78 Binding on activated 4-1BB-expressing CD4+ T cells and CD8+ T cells EC50 [nM] EC50 [nM] Construct 4-1BB+CD8+ 4-1BB+CD4+ Control B 0.05 0.26 Control C 0.02 0.30 Control D 0.04 0.28 Control E 0.13 1.22 3.1 0.03 0.28 3.3 0.01 0.29 3.4 0.15 2.04 3.5 0.04 1.03 3.6 0.05 0.21 9.2 Binding to CD19-Expressing Tumor Cells For binding assays on CD19-expressing tumor cells, the following human CD19-expressing lymphoma cell lines were used: diffuse large non-Hodgkin B cell lymphoma (B-NHL) cell line SU-DHL-8 (DSMZ ACC573), acute B cell precursor lymphoid leukemia cell line Nalm6 (DSMZ ACC-128), diffuse large cell lymphoblast lymphoma cell line Toledo (ATCC CRL-2631) and Article Title: Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer Article Snippet: .. TABLE 78 Binding on activated 4-1BB-expressing CD4+ T cells and CD8 + T cells EC50 [nM] EC50 [nM] Construct 4-1BB+CD8+ 4-1BB+CD4+ Control B 0.05 0.26 Control C 0.02 0.30 Control D 0.04 0.28 Control E 0.13 1.22 3.1 0.03 0.28 3.3 0.01 0.29 3.4 0.15 2.04 3.5 0.04 1.03 3.6 0.05 0.21 9.2 Binding to CD19-Expressing Tumor Cells For binding assays on CD19-expressing tumor cells, the following human CD19-expressing lymphoma cell lines were used: diffuse large non-Hodgkin B cell lymphoma (B-NHL) cell line SU-DHL-8 (DSMZ ACC573), acute B cell precursor lymphoid leukemia cell line Nalm6 (DSMZ ACC-128), diffuse large cell lymphoblast lymphoma cell line Toledo (ATCC CRL-2631) and Article Title: Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules Article Snippet: .. TABLE 78 Binding on activated 4-1BB-expressing CD4+ T cells and CD8+ T cells EC50 [nM] EC50 [nM] Construct 4-1BB+CD8+ 4-1BB+CD4+ Control B 0.05 0.26 Control C 0.02 0.30 Control D 0.04 0.28 Control E 0.13 1.22 3.1 0.03 0.28 3.3 0.01 0.29 3.4 0.15 2.04 3.5 0.04 1.03 3.6 0.05 0.21 9.2 Binding to CD19-Expressing Tumor Cells For binding assays on CD19-expressing tumor cells, the following human CD19-expressing lymphoma cell lines were used: diffuse large non-Hodgkin B cell lymphoma (B-NHL) cell line SU-DHL-8 (DSMZ ACC573), acute B cell precursor lymphoid leukemia cell line Nalm6 (DSMZ ACC-128), diffuse large cell lymphoblast lymphoma cell line Toledo (ATCC CRL-2631) and |